Stanley Druckenmiller (Duquesne Family Office) exit SpringWorks Therapeutics, Inc.
Stanley Druckenmiller (Duquesne Family Office) exit $-27.2K of disclosed value in SpringWorks Therapeutics, Inc..
Signal
Investor Move
Action
Exit
Capital
$-27.2K disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.